The CoC Source - October 31, 2011
(Print All Articles)
Commission on Cancer Holds Annual Meetings
The 97th Annual Clinical Congress of the American College of Surgeons just concluded in San Francisco with record attendance by more than 9,000 physicians. The Commission on Cancer held several sessions for the attendees. Agendas and related PowerPoint presentations will be posted to the CoC Meetings and Events page of the CoC Website by mid-November. Highlights from the meetings are as follows:
- The CoC hosted three scientific sessions focused on cancer survivor follow-up, management of upper GI tumors, and surgical management of metastatic disease.
- Monica Bertagnolli, MD, FACS delivered the CoC Oncology Lecture on Translational Cancer Research: Playing to Win in a Team Sport.
- A Town Hall session was held to educate physicians on applying the CoC metrics in your cancer program.
- Several new CoC State Chairs were oriented to their role and the 64 CoC State Chairs participated in a town hall session to discuss utilization of the National Cancer Data Base (NCDB) tools to assess cancer care at the state level along with a review of the data available from the Cancer Control P.L.A.N.E.T accessible from www.cancercontrolplanet.org.
- Representatives from the CoC’s 48 member organizations gathered to begin to define a role for advocacy efforts within the CoC in partnership with its member organizations, and learned about the advocacy agendas of the American Cancer Society, Association of Community Cancer Centers, and LIVESTRONG.
- The CoC Annual Meeting was attended by more than 200 individuals and included the election of new members and officers (see other article in this issue), an update on the current activities of the CoC, the formation of the Alliance for Clinical Trials in Oncology (ACTION), and the recent evaluation results of the National Cancer Institute’s Community Cancer Centers Program (NCCCP). The keynote presentation was delivered by Wells Shoemaker, MD, Medical Director of the California Association of Physician Groups. He addressed Accountable Care of the Near Future: Professional Leadership and Cancer. The meeting concluded with a review of the contributions by Richelle Williams, MD, the CoC Clinical Scholar working with the NCDB through June 2012.
- Finally, more than 300 cancer liaison physicians (CLPs) attended their annual breakfast meeting and received a program brief along with critical information to support them in their new role. Presentations included a review of the new CoC standards and a demonstration of the NCDB reporting tools. CLPs also had time for table discussions with their state chairs. The CLP meeting was recorded and is now posted to the CoC Website in the News section and on the Cancer Liaison program Information Board.
CoC Members and Member Organization Representatives Recently Appointed
The CoC welcomes the following individuals who were appointed to membership during the 2011 annual meeting, which was held on October 23, in San Francisco, CA.
Representing the Fellowship for a Three-Year Term:
Stephen J. Dreyer, MD, FACS; Freemont Area Medical Center, Fremont, NE
Matthew Facktor, MD, FACS; Geisinger Medical Center, Danville, PA
Paul T. Finger, MD, FACS; The New York Eye Cancer Center, New York, NY
Steven N. Hochwald, MD, FACS; Shands at the University of Florida, Gainesville, FL
Terry Sarantou, MD, FACS; Carolinas Healthcare System, Charlotte, NC
Steven D. Wexner, MD, FACS, FRCS, FRCS(Ed); Cleveland Clinic Hospital, Weston, FL
Representing Member Organizations for a Three-Year Term:
American Radium Society - John Andrew Ridge, MD, PhD, FACS; Fox Chase Cancer Center; Philadelphia, PA
American Society of Breast Surgeons - James Bishop Lockhart, Jr., MD; Surgical Associates, Inc.; Tulsa, OK
Department of Veterans Affairs / Veterans Health Administration - David H. Berger, MD, , FACS, MHCM; Baylor College of Medicine; Houston, TX
Society of Nuclear Medicine - Eric M. Rohren, MD, PhD; University of Texas M. D. Anderson Cancer Center; Houston, TX
Representing the Leadership:
Daniel P. McKellar, MD, FACS; Wayne HealthCare; Greenville, OH - Chair Elect, CoC
Linda W. Ferris, PhD; Oncology-Centura Health; Denver, CO – Vice-Chair, Accreditation Committee
Phillip Y. Roland, MD, FACS, FACOG; St. Francis Hospital and Medical Center; Hartford, CT - Chair, Cancer Liaison Committee
Mary J. Milroy, MD, FACS; Avera Sacred Heart Hospital; Yankton, SD; Vice-Chair, Cancer Liaison Committee
Howard L. Kaufman, MD, FACS; Rush University Medical Center; Chicago, IL - Co-Vice-Chair, Education Committee
CoC Recognizes Outgoing Members and Leadership
The CoC recognizes the following departing members for their distinguished contributions to the work of the Commission:
- Gildy V. Babiera, MD, FACS *
- Aaron D. Bleznak, MD, FACS *
- Barry W. Feig, MD, FACS *
- Jay K. Harness, MD, FACS - American Society of Breast Surgeons
- Henry T. Hoffman, MD, FACS *
- Scott A. Hundahl, MD, FACS, FSSO - Department of Veterans Affairs
- John S. Kennedy, MD, FACS *
- Robin S. McLeod, MD, FACS - Regental Advisor
- David M. Ota, MD, FACS - American College of Surgeons Oncology Group
- David F. Penson, MD, MPH, FACS - American Urological Association
- Erich M. Sturgis, MD, MPH, FACS - American Radium Society
- Elin Ruth Sigurdson, MD, FACS *
- Lawrence D. Wagman, MD, FACS *
- Marc K. Wallack, MD, FACS *
- Richard L. White, Jr., MD, FACS *
Aaron D. Bleznak, MD, FACS - Chair, Cancer Liaison Committee
- Robert M. Flanigan, MD, FACS – Vice-Chair, Accreditation Committee
- Phillip Y. Roland, MD, FACS, FACOG - Vice Chair, Cancer Liaison Committee
Representing the Cancer Programs Standards Project:
- Frederick L. Greene, MD, FACS - Chair
- Diana Dickson-Witmer, MD, FACS – Vice-Chair
CoC Hospital Locator: Patients Are Looking for Your Cancer Program
The CoC Hospital Locator is a tool patients are using to find your cancer program. The information available via the locator tool is helping patients make educated decisions about their cancer care.
Resource and service information and cancer caseload data provided by CoC-accredited cancer programs through the Facility Information Profile System (FIPS) is made publicly available via the CoC Hospital Locator. Here is a “how-to” refresher course on using the hospital locator:
1) Select the CoC Hospital Locator link from the right-hand menu on the CoC website, www.facs.org/cancer. You will be directed to a general information page that explains what CoC accreditation means and how accreditation benefits the cancer patient.
2) Click on the grey button labeled, “Find a CoC-Accredited Cancer Program Near You.”
This is the CoC Hospital Locator search page. At the top of the page there are a few links providing an explanation of accreditation, a glossary of terms used in the Locator, and some tips on how patients can use the Locator to meet their needs.
Now let’s search!
Here are the options when performing a simple search:
1) Search by Facility Name
2) Search by City/State (separately or together)
3) Search by ZIP Code – Please note that you can add a Radius Search to the ZIP Code Search. This search will be performed from the center of the ZIP Code
4) Search by Cancer Program Category – This search can also be combined with the City/State or ZIP Code search.
Before you click that Search button, please select how you want to view the results:
Detail Facility Listing (default listing style) - Detailed contact information, available resources and services, and cancer caseload information for facility/facilities that appear as the result of a search.
Summary Listing - Facility/facilities are listed by city and state as the result of a search, with links to detailed information. This results listing is best to use for a high-yield search.
There is also an Advanced Search by available services:
1) Select the link (Advanced Search by Services) at the top right of the Simple Search page.Note that all Advanced Search results will be displayed in a Detailed Listing format.
2) Enter the location information – Please note that by entering the location information you will receive a more precise list of results; however it is not necessary when performing an advanced search.
3) Select the service(s) you are looking for from the list. You can select more than one service at a time.
Bookmark the CoC Hospital Locator web page for faster access: http://www.facs.org/cancerprogram/index.html
Questions or comments can be directed to the CoC at mailto:firstname.lastname@example.org.
CoC Datalinks Access: Security and Maintenance
CoC Datalinks is a central repository for maintaining CoC-accredited cancer program data and information. This password-protected portion of the CoC website enables individuals on staff at CoC-accredited programs to access, provide, and utilize facility-specific information and data.
Designated staff persons at CoC-accredited facilities have access to the CoC Datalinks portal in the following roles:
• Cancer Committee Chair
• Cancer Liaison Physician
• Cancer Program Administrator
• Hospital Registrar
Facility staff in the roles above can request access for additional staff in the following roles:
• Hospital CoRegistrar
• Datalinks Contact
• NCDB Tools User
Access to CoC Datalinks is granted per individual, and the ID and password combination to CoC Datalinks is an individual identifier, NOT a facility-wide access log-in. Each staff person in one of the roles listed above has a unique log-in to access the CoC Datalinks portal.
For security purposes and to protect facility data, User IDs and Passwords are not to be shared. The CoC is not responsible for the unauthorized release or sharing of log-in information and data by any CoC Datalinks user.
For the security of your facility, it is important to ensure that the information listed in the Facility and Staff Contacts section of CoC Datalinks is current and accurate as it directly correlates with the CoC Datalinks access roles. Log into CoC Datalinks and select the facility and staff contacts application from the Activity Menu to review and update CoC Datalinks users at your facility. If you want to add additional CoC Datalinks users not already listed in the Facility and Staff Contacts section, complete and submit the CoC Datalinks User Request Form located on the CoC Datalinks log-in page.
Important notes about updating CoC Datalinks users:
1. Datalinks Contact and NCDB Tools User roles are not listed in the Facility and Staff Contacts section of CoC Datalinks. Please e-mail CoCDatalinks@facs.org to obtain a full listing for your facility.
2. In the event of the termination of a user, it is the responsibility of the user or cancer program leadership to contact the CoC at CoCDatalinks@facs.org so we can immediately inactivate the user. Note that when you update contact information for the facility or staff in CoC Datalinks, the CoC internal records are not immediately updated. Please e-mail CoCDatalinks@facs.org with all staff changes.
3. “Primary Contact Person” in the Facility and Staff Contacts application is not an access role. This field is used only for survey notification and surveyor contact purposes.
Questions? Contact CoCDatalinks@facs.org
Applications Being Accepted - American College of Surgeons Commission on Cancer Surgical Oncology Scholar-in-Residence Program
The American College of Surgeons (ACoS) Commission on Cancer (CoC) is offering a two-year fellowship in surgical oncology outcomes and health services research beginning July 1, 2012. The ACoS CoC has one position available every two years for a surgical resident who has completed two or three years of clinical training in the United States or Canada. The fellow will work within the Cancer Programs Department of the ACoS to conduct clinical research and further the research agenda of the CoC’s National Cancer Data Base (NCDB) whose goal is to improve the quality of care for the cancer patient. The application deadline is November 1, 2011.
Details about the program can be found on the CoC Web site at http://www.facs.org/cancer/cannews.html.
Program questions and completed applications with supporting documentation should be directed to Connie Bura, Administrative Director of Cancer Programs at the ACoS, at email@example.com
Changes to the Survey Agenda
Starting in 2012, the CoC survey agenda will have some changes and enhancements based on feedback provided by our accredited cancer programs and surveyor team.
The Chief Leadership Meeting will continue, however, this session will be extended to approximately 45 minutes and will include the entire cancer team (cancer committee members). We are anticipating that key members of the facility administration will participate in this session, including the Chief Financial Officer (CFO) or other administrator responsible for facility budgeting and operations. It is also important to include the Chief or Vice-President of Quality and Patient Safety along with a representative from Marketing or Business Development. All members of the administration are encouraged to participate in the Cancer Team Meeting which includes the Cancer Committee Chair, Cancer Liaison Physician and other members of the cancer committee.
The Cancer Team Meeting will last an additional 90-120 minutes during which the surveyor will review and discuss program activity, go over required materials, and present a brief introduction to the new patient-centered standards for team discussion. We have also added the option for the cancer program to offer a 15 minute power point presentation to the surveyor that emphasizes a specific cancer program accomplishment, enhancement or best practice which took place during the 2009 – 2011 survey period. This presentation may be given by any member of the cancer committee and this should be determined and included in the final survey agenda.
The other change to the survey agenda is the facility tour. This activity is now optional and should be discussed with the surveyor as the agenda is planned. If included, the tour should include specific areas that are discussed in advance and not exceed 60 minutes.
The final agenda change is the review process for standards 3.3 (abstracting timeliness) and 4.6 (CAP protocols) which now allows for all 30 charts to be pre-selected by the surveyor within 5-14 days in advance of the survey. This change allows for the person responsible for providing the accession list to work directly with the surveyor to choose appropriate surgically resected analytic cases that need to follow the CAP protocols. Choosing cases in advance of the visit enables the person responsible for this portion of the review to focus on the survey itself during the on-site visit. Once the 30 cases are selected the information for each case can be entered into the SAR in advance of the survey.
We are confident that these changes and enhancements will help the survey process flow more smoothly and allow additional time for discussion between the surveyor and the cancer team.
A sample survey agenda for 2012 will soon be added to the CoC website. Your assigned surveyor will provide an electronic copy of the sample survey agenda when they provide initial survey communication beginning in December, 2011.
Please submit questions about the 2012 survey agenda and the new Cancer Program Standards to the CAnswer Forum at www.cancerbulletin.facs.org/forums/
Reminder: The SAR Is Not Closing
Reminder: The Survey Application Record (SAR) will NOT close on October 31, 2011. This is the end date for accredited programs to complete their SAR with cancer program activity and uploaded documents from 2008 through June 2011 for the SAR Annual Update. During this time, the CoC will take a ‘snapshot’ of the SAR and the documents for historical purposes. The survey SAR and/or Tracking Activity SAR will not close down during this time.
Programs should continue to update the SAR with 2011 cancer program activity and appropriate documents (for example, minutes and conference grids) throughout 2011 and through mid-year of 2012. Programs scheduled to be surveyed in 2012 will be able to edit the survey SAR and upload additional documents until the time of their survey. Surveys from 2012 will include cancer program activity from 2009, 2010, and 2011. Activity taking place in 2012 will be entered in the NEW SAR that is scheduled to become available mid-2012.
Highlighting the 2012 Standards – Chapter 1: Program Management
Last month we highlighted several standards in Chapter 1 which address the cancer committee’s organization and structure. This month we review standards that form the basis for 5 areas that are integral to program leadership. As mentioned last month, all standards are the responsibility of the cancer committee as these standards help the committee coordinate, assess, and lead the cancer program to provide the highest quality care close to home.
Let’s explore the next 5 standards in chapter 1.
Standard 1.5: Cancer Program Goals
Cancer program goals allow the cancer committee the flexibility to establish meaningful challenges related to clinical and programmatic activity. The clinical goal addresses issues related to diagnosis, treatment, and care of the program’s patients. A programmatic goal is directed toward the scope, coordination, and processes of care for patients in the cancer program.
At least one goal in each area is to be identified annually by the cancer committee with the progress toward achieving the goal to be monitored and evaluated at least twice during the year. As expected, the evaluation is documented in cancer committee minute. Be aware that, goals are not be a restatement of a current standard but something beyond already established requirements for accreditation.
Use the recommended – SMART goal-setting acronym:
Goals must be Specific (example: increase access to mammography screening)
Goals must be Measurable (example: current hours are Monday-Friday during the day, add weekend hours and evening hours for more access)
Goals must be Achievable (example: contract with two additional mammography technicians one for evenings and one for weekends)
Goals must be Realistic: (example: the cost of contracting technicians vs. reimbursement by insurance or self-pay will allow this to be a budget neutral expansion of services)
Goals must be Timely: (example: it will take 3 months to hire the contract staff and expanded hours should begin within 6 months)
Documentation of the SMART steps is critical to compliance for this standard. Be sure to keep the goals on the agenda until the each one is met. Goals are intended to be completed annually. However, if not completed, these may roll into the next year as long as two new goals are established during the next year. Remember to use the Survey Application Record (SAR) as a tracking tool to record the review dates and goal status, along with uploading documentation of activity that is recorded in cancer committee minutes.
Standard 1.6: Cancer Registry Quality Control Plan
Quality control (QC) of cancer registry data is essential to ensure accurate data collection that is used for assessment of treatment and outcomes. The Cancer Registry Quality Control Coordinator is responsible for working with the cancer committee to establish a plan to monitor and evaluate data. Specific review criteria, timetables and QC methods, and personnel involved are included in the plan which may or may not include external audits from state or central registries. The standards outline very specific minimum activities for evaluation along with the minimum and maximum analytic caseload review requirements (10% minimum, 300 case maximum). The plan must also include minimum quality benchmarks for accuracy which are established by the cancer committee.
Documentation of the QC plan along with a report of the annual review findings must be included in the cancer committee minutes to comply with the standard. If any areas fall below requirements an action plan must be developed to resolve these issues.
The standard lists exceptions and variations for NCIP and VA categories so please review the manual to obtain more specific information.
Standard 1.7: Monitoring Conference Activity
Cancer conferences are intended to provide a multidisciplinary consultative service to patients with cancer with a goal of improving patient care. There are 7 specific areas that are essential for compliance with the standard. The cancer conference coordinator leads this important initiative to establish requirements for the cancer conference program and evaluate and report activity to the cancer committee at least once each year.
The areas that are to be addressed in the cancer conference policy include:
How often the conference will be held (frequency)
Whether site specific conferences or general conferences will be held (format)
Which physician and allied health professionals are to attend and how often (attendance and attendance rate)
How many cases and what type of cases will be presented (15% of the analytic case volume minimum and 80% prospective case mix)
Content of case discussion (stage, prognostic indicators, treatment planning that uses evidence-based guidelines
Options for clinical trial access
The cancer committee may determine the best method to track and report cancer conference activity. The activity and discussion are documented in the cancer committee minutes. If any area falls below the goal or requirement set by the cancer committee, then an action plan should be initiated to improve performance.
Standard 1.8: Monitoring Community Outreach
Community outreach activities are based on a specific community need for prevention and early-detection programs. Organizing and offering these programs falls under standards 4.1 and 4.2.
The Community Outreach Coordinator oversees the outreach activity including monitoring the effectiveness of community outreach programs and develops a community outreach summary which is shared with the cancer committee at least once each year.
The Community Outreach Coordinator is selected based on their skill, knowledge and interest in community outreach activities. It is imperative that the coordinator be employed by the facility and is also a member of the cancer committee. The coordinator should work in collaboration with facility departments and/or external organizations to develop this outreach activity.
Standard 1.9: Clinical Trial Accrual
Clinical research is essential to patient care to advance cancer care overall.
The clinical trial coordinator or representative is identified by each program and should be chosen based on clinical knowledge and skills related to clinical trials. Examples of individuals who could be chosen to fill the role of clinical trial coordinator include a principal investigator, data manager, research associate, or nurse who utilizes appropriate clinical trial resources. The clinical trial coordinator or representative reports the enrollment activity to the cancer committee at least once per year.
Patients who are diagnosed and/or treated for cancer may be placed on a cancer-related clinical trial either within the facility, through physician offices, or referral to or from an external facility. Prevention or early detection clinical trials allow any patient to enroll with the appropriate IRB approval and patient informed consent. Available cancer-related clinical trials may be available from various sources including, but not limited to: NCI cooperative groups, pharmaceutical or locally developed investigator initiated clinical trials.
With the exception of Hospital Associate Cancer Program, all categories of accredited cancer programs are required to enroll a minimum percentage of patients each year into cancer-related clinical trials. Documentation of the enrollment numbers and/or percentages are included in the SAR and reported to the cancer committee by the clinical trial coordinator or representative at least annually.
New category-specific compliance and commendation level percentages are set forth in the new cancer program standards manual. The new compliance and commendation levels presented there apply to programs beginning in 2015.
These 5 standards outline several of the important roles and responsibilities for program coordinators who are chosen to assist the cancer committee with meeting or exceeding the programmatic standards. The remaining 3 standards in this chapter continue to outline important responsibilities of the cancer committee. These will be discussed in the next issue of the CoC Flash.Next month – Chapter 1: Program Management, Standards 1.10 – 1.12
Check Out the Cancer Liaison Program Website’s New Look
If you’ve visited the Cancer Liaison Program website recently, you have no doubt noticed some changes. The website has been redesigned to be more informational and less wordy. Information has been updated, and navigation has been streamlined.
Information on the State Chair and Cancer Liaison Physician (CLP) Information Boards has been updated. The CLP Information Board contains a new CLP Toolkit with updated Role and Responsibilities description, CLP Checklist, CLP Activity Report PDF, and FAQs. There are links to each CLP webinar as well as instructions for accessing them. New to the Information Board are tip sheets and navigation guides for the National Cancer Data Base Hospital Comparison Benchmark Reports, Survival Reports, and Cancer Program Practice Profile Reports. Links to American Cancer Society (ACS) resources are also featured as well as contact information for your ACS representative and state chair.
The State Chair Information Board contains the revised State Chair Toolkit, which can be downloaded or printed, National Cancer Data Base reporting tools tip sheets, sample Activity Reports, and a forms section.
Check out the redesigned site at http://www.facs.org/cancer/clp/index.html. If there is additional content you would like to see on the Information Boards, please advise us at firstname.lastname@example.org.
Congratulations State Chair Outstanding Performance Award Recipients
Each year, the CoC Committee on Cancer Liaison distributes up to three Outstanding Performance Award to State Chairs who have exhibited outstanding leadership and innovation, and made significant contributions to the improvement of cancer care in their state or region. The awards are based on consistent and innovative communication methods used for maintaining relationships with the Cancer Liaison Physicians, support and initiation of CoC activities at the state/regional level, and collaborative activities with the local College Chapter, American Cancer Society, and/or Comprehensive Cancer Control.
Congratulations to the 2011 winners of the Outstanding Performance Awards:
J. David Beatty, MD, FACS
Dr. Beatty serves as the State Chair of Washington. He practices at the Swedish Cancer Institute (Swedish Medical Center) in Seattle, WA.
Jarrod Kaufman, MD, FACS
Central State Healthcare System
Dr. Kaufman serves as the State Chair of New Jersey. He practices with Advanced Surgical Associates of New Jersey and is affiliated with Central State Healthcare System in Freehold, NJ.
Barry Landry, MD, FACS
Thibodaux Regional Medical Center
Dr. Landry serves as the State Chair of Louisiana. He practices with Thibodaux Surgical Specialists and is on the staff of Thibodaux Regional Medical Center, where he has served as Chief of Staff.
CLP Breakfast Meeting Webcast Available
A webcast of the CLP Breakfast Meeting on October 24, 2011 in San Francisco is now posted on the CoC home page in the “News and Updates” box, and on the Cancer Liaison Physician Information Board. Presentations given at the CLP Breakfast include an update of the CLP Outstanding Performance Award process, highlights of the revised CLP Information Board, an overview of the 2012 Cancer Program Standards and information on the National Cancer Data Base Rapid Quality Reporting System (RQRS).
CLP Webinar Series
The Cancer Liaison Physician (CLP) webinar series consists of five webinars. The next few issues of the CoC Flash will feature descriptions of each webinar.How to Navigate the National Cancer Data Base Tools: A Primer, the third webinar in the CLP educational series, is a primer on the Commission on Cancer’s CoC Datalinks and the National Cancer Data Base (NCDB) tools. The 12-minute presentation instructs the CLP on how to access the tools developed by the NCDB for use by CoC-accredited cancer programs. The NCDB applications are briefly described and possible uses suggested.
You can access this webinar through the Commission on Cancer (CoC) Online Education portal at http://eo2.commpartners.com/users/acs/. Additionally required CLP webinars on the portal include topics on how to analyze and report the data from the quality tools, becoming a liaison to the American Cancer Society, and a general orientation to the CLP role. The webinar series must be completed by January 1, 2012.
Questions on the webinar series can be directed to email@example.com.
American Cancer Society and the Commission on Cancer Collaborate to Support CoC-Accredited Facilities Meet 2012 Standards
As a key collaborator with the CoC, the American Cancer Society (ACS) is seeking to enhance its ability to support the 2012 Cancer Program Standards. Toward this end, the ACS and the CoC collaborated on a document, Cancer Program Standards 2012: Ensuring Patient-Centered Care, a Guide for ACS Field Staff and CoC-Accredited Programs to identify ACS resources that will support specific standards. The guide presents key highlights of the 2012 standard revisions and matches ACS resources with the following standards:
In addition, the guide describes how the role of the cancer committee has changed or will be impacted by the new standards, and how ACS field staff can support CoC programs. Of particular note is a list of ACS resources that specifically support Cancer Liaison Physicians in their expanded role.
- Patient-centered and continuum of care standards
- 2.3: Risk Assessment and Genetic Counseling
- 2.4: Palliative Care Services
- 3.1: Patient Navigation Process
- 3.2: Psychosocial Distress Screening
- 3.3: Survivorship Care Plan
- Patient outcome standards
- 1.8: Monitoring Community Outreach
- 1.9: Clinical Trial Accrual
- 4.1: Prevention Programs
- 4.2: Screening Programs
- Eligibility criteria
- E9: Clinical Trial Information
- E10: Psychosocial Services
- Cancer Liaison Physician, Standard 4.3
The guide can be downloaded from the Cancer Liaison Physician Information Board at http://www.facs.org/cancer/coc/physresource.html.
What’s Next for the NCDB Call for Data?
There is one more data submission month for the 2011 NCDB submission cycle in November, before annual submissions begin in January 2012. The National Cancer Data Base (NCDB) thanks registries for their vigilance in following the transition submission schedule during the past year.
Due in November: Cases diagnosed in 1999 that were modified by the registrar since July 1, 2005, and cases diagnosed in 2000 that were modified since July 1, 2006, must be submitted during November 2011, specifically by midnight (CT), the night of November 30. If these diagnosis years precede the program’s Reference Date, they are not to be submitted. Also due in November are:
- Any cases diagnosed in 2005 and submitted in September that have outstanding data quality problems;
- Any cases diagnosed in 2002 or 2005 (and since your Reference Date) that were rejected in September;
- Corrections for edit problems for cases diagnosed in 2002 or earlier are appreciated, but are not required by Standard 3.6.
NCDB will be closed for submissions during the month of December to prepare for the 2012 Call for Data.
Due in January: In January, NCDB enters its new annual cycle in which all case reports are collected for the diagnosis year that ended a full year earlier, and any cases that have been updated by the registrar since they were last requested in a Call for Data. Due in January are:
- All analytic cases diagnosed in 2010;
- All analytic cases for diagnosis years 1985 (or the program’s Reference Date, whichever is later) through 2009 that have been added to the registry or modified since shortly prior to the respective Call for Data.
The full schedule and information about the changes in NCDB’s submission cycle are posted at http://www.facs.org/cancer/ncdb/registrars.html. The official NCDB Call for Data will be distributed as a special NCDB Flash in November.
NCDB recommends that programs follow software provider instructions to select cases for submission in 2012 rather than attempt the complex manual selection. The deadline for submitting all cases due in January is midnight (CT), the night of January 31. NCDB continues to recommend submitting cases earlier in the month if possible. Other pre-Call for Data information was published in the September CoC Flash (http://newsmanager.commpartners.com/acscoc/issues/2011-09-30/14.html).
Reminder: The schedule for collecting only newly abstracted and changed records is based on the expectation that cases are not pulled for submission any earlier than the month preceding the respective Call for Data. If the submission files are created earlier, some changes may fail to be transmitted. If you created your submission file for cases diagnosed in 1999 or 2000 before October 1, please recreate the file before submitting it in November. Likewise, do not create your final files for submission in January until December 1 or later. Of course, you may create test files earlier to use to pre-clean your data for submission.
Survey Savvy Takes on Hollywood
In mid-September, the Commission on Cancer hosted more than 200 participants at the “World Premier of the 2012 Patient-Centered Standards,” the Survey Savvy workshop held in Hollywood, CA. Best practices were shared by staff and experienced constituency alike.
The National Cancer Data Base (NCDB) presented a new workshop on using the recently launched Rapid Quality Reporting System (RQRS). A special thanks goes to Cancer Support Community for providing giveaway bags to all attendees. Survey Savvy and the RQRS workshop will be held again in Chicago, IL, March 7–9, 2012. Save-the-date, as registration will open in early December.
New Webinars Now Available On-Demand
The following webinars are now available for viewing On-Demand.
Visit the CoC Online Education Portal and register today to view these webinars.
Move to the Fast Track: Getting Your Cancer Program Ready for the Rapid Quality Reporting System (RQRS)
The Rapid Quality Reporting System (RQRS) is a new program from the NCDB, designed to promote evidenced-based cancer care at the local level in real clinical time. Participation in this program is voluntary; enrollment will open in the spring of 2011. This webinar will explain how CoC-accredited cancer programs can get ready to enroll and begin to actively participate in the RQRS. The enrollment process will be briefly reviewed. Information gathered from alpha and beta test participants explaining how RQRS participation was managed in individual cancer programs will be reported. Examples and best practices on how beta test participants came to concurrently abstract breast, colon and rectum cases will be shared, as well as the instructions for data submission. Select benefits and challenges of RQRS participation will also be described.
The College of American Pathologists (CAP) Cancer Protocols: Where We’ve Been and Where We’re Going
During the past quarter century, significant strides have been made in the delivery of multidisciplinary care to cancer patients. The medical team includes surgeons, medical oncologists, radiation oncologists, pathologists, radiologists, nurses as well as numerous other ancillary professionals. As part of this transition, the Cancer Committee of the College of American Pathologists (CAP) recognized the need for more uniform and complete pathology reports to further aid in the delivery of high quality care to cancer patients. To work toward this goal, the CAP Cancer Committee wrote and published the first set of the "Cancer Protocols" in 1986. Since that time significant changes and additions to the protocols have been implemented. This Webinar will present the history and development of the "Cancer Protocols", explain their function, and emphasize the importance of complete pathology reports in the care of cancer patients. It will also discuss the endorsement of the protocols by the American College of Surgeons Commission on Cancer as well as review the Commission on Cancer's standard for accreditation scheduled for implementation in 2012.
Visit the CoC Online Education Portal and register today to view these webinars.
Preparing for Your CoC Survey
This webinar is designed to assist cancer programs with preparation for their accreditation survey. No matter when your next survey will take place, it is never too early to start the process to prepare. This 45 minute pre-recorded webinar gives you and your cancer program leadership a high-level overview of the process; from electronic notifications to post survey steps, and all steps in between. Go to http://www.facs.org/cancer/coc/programresources.html and click on "Preparing for Your CoC Survey" to access this webinar.
New On-Demand Webinars to Support the CoC Standards Coming Soon
Cancer Programs Standards 2012:
Continuum of Care Services:
- Cancer Program Standards 2012 Chapter 1: Focus on Roles and Responsibilities of the Cancer Committee
- Cancer Clinical Trials
- Eligibility Requirements: The Cancer Committee’s Role in Evaluation and Reporting
- Quality of Patient Care: New CoC Standards
- Studies of Quality and Quality Improvements
- Important Accreditation Facts: New Program Categories, Accreditation Awards, and the OAA
- 2012 and Beyond: The Survey Process
- Focus on Survivorship Care Plans
- Introduction to Patient Navigation Part 1
- Introduction to Patient Navigation Part 2
- Psychosocial Distress Screening, Tools, and Resources
- A Palliative Care Primer
- Cancer Risk Assessment and Genetics Testing
These titles will be added to the On-Demand registration page soon.
AJCC Member Organization Representatives Recently Appointed
The American Joint Committee on Cancer (AJCC) welcomes the following individuals who were appointed to membership during the 2011 annual meeting, held on September 24 in Chicago, IL.
Representing Member Organizations for a three-year term are:
• American Cancer Society: Robert K. Brookland, MD, GBMC Healthcare, Inc., Baltimore, MD
• North American Association of Central Cancer Registries: Maria J. Schymura, PhD; New York State Cancer Registry, Menands, NY
• Society of Urologic Oncology: Fernando J. Bianco, MD, Columbia University, Mt. Sinai Medical Center, Miami Beach, FL
The AJCC also recognized the following outgoing members for their distinguished service:
Mahul B. Amin, MD, FCAP (College of American Pathologists)
Ermilo Barrera, Jr., MD, FACS (American Cancer Society)
Al B. Benson III, MD (American College of Physicians)
Sam S. Chang, MD (Society of Urologic Oncologists)
David B. Duggan, MD, MACP (American College of Physicians)
Sheila A. Prindiville, MD, MPH (National Cancer Institute)
Susan Sabatino, MD, MPH (Centers for Disease Control and Prevention)
Colleen Sherman, RHIA, CTR (North American Association of Central Cancer Registries)
Alan G. Thorson, MD, FACS (American Cancer Society)
Mary Kay Washington, MD, PhD (College of American Pathologists)
CS Website Survey
The Collaborative Stage (CS) team is planning a redesign of the CS website. We are seeking input from users of the CS website to ensure that the new version is informed by the opinions of those who use the website most often. Our goals are to improve the website navigation, content, and functionality.
The following survey has been created to gather feedback and suggestions that will inform the redesign of the CS website. http://www.surveymonkey.com/s/CS_user_survey
Please take a few moments to provide us with your valuable input . The survey should take approximately 10-15 minutes to complete.
If you have any questions, please email firstname.lastname@example.org
New Collaborative Stage Videos on YouTube!
The American Joint Committee on Cancer (AJCC) announced the launching of its YouTube channel last spring. Recently, two new videos have been added on important issues related to Collaborative Stage (CS). The two new videos are CS Moments: 988 vs. 999 and the Proper Usage, and CS Moments: Hierarchical Coding Structure. If you have not visited the YouTube Channel yet, be sure to check out these new videos along with the older ones and leave some feedback in the comments section.
The YouTube channel is a new way to present educational information and interact with the oncology and registry community.. Users can “subscribe” to the AJCC channel and be notified when new videos are posted. Be sure to use the all the features below the video display and leave feedback in the comments section, give a thumbs up if you like the video, and of course, share the video with colleagues. The AJCC will monitor the comments and feedback sections of the individual videos as well as the AJCC channel page for users input and suggestions. Click here to check out the AJCC on YouTube!
NAPBC Welcomes Radiology Organizations to the Board
The National Accreditation Program for Breast Centers (NAPBC) warmly welcomes the following radiology-based organizations to the NAPBC Board:
• American College of Radiology Commission on Breast Screening
• American College of Radiology Imaging Network
• American Institute of Radiologic Pathology
• Society of Breast Imaging
Contributions by these organizations will help shape NAPBC standards. A complete listing of NAPBC Board organizations is located on the NAPBC website at www.napbc-breast.org.
Standard Changes on the Horizon for 2012
The NAPBC Standards and Accreditation Committee has reviewed two standards and proposed changes to the following:
• Standard 2.5 – Breast Cancer Surveillance
• Standard 2.16 – Genetic Evaluation and Management
Both standards are being edited to clarify the purpose and requirements and provide additional resources in order to comply with each.
Standard 6.2 – Quality Improvement…Is Coming
The NAPBC Quality Improvement and Information Technology Committee has proposed the development of a new standard that will require aggregate data reporting on an annual basis to allow centers to evaluate care within their center and compare their performance across all NAPBC-accredited centers for seven breast cancer performance measures. A data collection page will be added to the Survey Application Record that will require all NAPBC-accredited breast centers to enter information on an annual basis. For centers that are affiliated with a Commission on Cancer- (CoC)-accredited facility, this information is already being collected through the National Cancer Data Base and appears in the Cancer Program Practice Profile Report (CP3R). For centers that are not accredited by the CoC, a simple, self-calculating form will be included as part of the data collection page. This form has been formulated to mirror the calculation that produce performance rates for centers affiliated with CoC-accredited facilities, and will allow all NAPBC-accredited breast centers to compare their performance to the performance of other NAPBC-accredited breast centers.The NAPBC SAR data collection page will be pilot-tested in early 2012 and rolled out to all accredited centers and those applying for accreditation by mid-2012. Additional educational resources will be made available prior to implementation.
NAPBC Ad Campaign Emphasizes Multidisciplinary Care
NAPBC kicked off its 2011–2012 ad campaign during Breast Cancer Awareness month (October) this year. Watch for the NAPBC ad in the following journals:
- Oncology Issues (September/October 2011)
- The Breast Journal (September/October, November/December, January/February, March/April, May/June, July/August)
- CA-A Cancer Journal for Clinicians (September/October, November/December, January/February, March/April, May/June, July/August)
- ACR Bulletin (October 2011)
NAPBC Exhibit Schedule
The NAPBC is scheduled to exhibit at the following national meetings:
San Antonio Breast Cancer Symposium (SABCS)
December 6-10, 2011
Henry B. Gonzalez Convention Center
San Antonio, TX
National Consortium of Breast Centers
March 10-14, 2012
Planet Hollywood Casino and Resort
Las Vegas, NV
American Society of Breast Disease
April 12-14, 2012
Four Seasons Resort
American Society of Breast Surgeons
May 2-6, 2012
JW Marriott Desert Ridge Resort and Spa
Stop by the exhibit hall at any one of these meetings and pick up an NAPBC Information Kit or additional information about the program.
NAPBC Partners with the National Consortium of Breast Centers
Quality care has become the new definition of value in health care. Initiatives to assess quality care exist for breast centers as a program and for each clinical discipline. Each program has a spectrum of measures designed to assess its own discipline. Most quality programs reside as stand-alone programs but in the future, synergy among programs will produce collaboration and increased consistency in quality care. An overview of the quality assessment landscape helps facilities choose which programs to engage.
A special preconference meeting titled National Recognition for Breast Centers of Excellence: Service Line Optimization will be held in conjunction with the National Interdisciplinary Breast Center Conference. This meeting will take place on Saturday and Sunday, March 10-11, 2012. Speakers on Saturday, March 10, will include well-known national leaders in quality breast health care. Presentations will include discussions of a number of quality initiatives available to track quality improvement over time. On Sunday, March 11, the NAPBC, continuing the theme of quality breast health care, have invited speakers to discuss the actual programs within the breast center model that contribute to quality breast health care. These efforts include building a multidisciplinary team, discussing the NAPBC components and standards that are required for NAPBC accreditation, continuity of care and how survivorship programs augment multidisciplinary care, the importance of genetic counseling, and a discussion of NAPBC accreditation.
Learn more about the programs during the 22nd Annual National Interdisciplinary Breast Center Conference, March 10–14, 2012, at the Planet Hollywood and Casino in Las Vegas, NV. Learn more as well about the National Quality Measures for Breast Centers and the NAPBC.
Contact the National Consortium of Breast Centers for more information and to enroll for this comprehensive educational meeting or contact the NAPBC administrative office at email@example.com.
National Partners for Comprehensive Cancer Control Policy Workshop
The National Partners for Comprehensive Cancer Control, of which the CoC is a partner, held a national State and Tribe/Tribal Organization Comprehensive Cancer Control Policy Workshop on August 24–25, 2011, in Lincolnshire, IL. The two-day workshop focused on the implications of the Affordable Care Act (ACA) for comprehensive cancer control (CCC) coalitions, identified CCC coalition opportunities to advocate and/or prepare for ACA implementation in their state, and defined ways in which the ACA might change CCC coalition priorities and opportunities. The keynote address was given by Dr. Jeffrey Levy, Executive Director of Trust for America’s Health, who emphasized the opportunities presented by the ACA for cancer coalitions, especially in the areas of community-based prevention programs, development of safe and healthy community environments, empowering people to make healthy choices, and elimination of health disparities. Other speakers delivered presentations on ACA provisions addressing cancer-related issues in Medicaid, Medicare, and state funding; the impact of the ACA on American Indian Cancer Policy and disparities in cancer care; and advocacy and action strategies for improving public education and influencing legislation. State coalitions were asked to consider realigning their plan priorities to best implement the ACA in their state. The workshop was well-attended with 101 participants representing 42 state, tribe/tribal organization, and U.S. Territory (Puerto Rico) coalitions, as well as several cancer advocacy organizations.
Great American Smokeout - 2011
Tobacco use is responsible for nearly one in five deaths in the United States, resulting in an estimated 443,000 premature deaths each year. Approximately half of an estimated 46 million adults in the U.S. who currently smoke will die prematurely from smoking. At least 30 percent of all cancer deaths and 87 percent of lung cancer deaths can be attributed to tobacco use.
The American Cancer Society is marking the 36th Great American Smokeout on November 17, 2011. The Great American Smokeout event grew out of a 1971 event in Randolph, MA, in which Arthur P. Mullaney, a guidance counselor at Randolph High School, asked people to give up cigarettes for a day and donate the money they would have spent on cigarettes to a high school scholarship fund. The idea caught on, and on November 18, 1976, the Society’s California Division Society succeeded in getting nearly one million smokers to quit for the day. The first Great American Smokeout was held in 1977. Over the past 34 years, the Great American Smokeout has been chaired by some of America's most popular celebrities, including Sammy Davis, Jr., Edward Asner, Natalie Cole, Larry Hagman, Surgeon General C. Everett Koop, and the first "spokespud" Mr. Potato Head.
The American Cancer Society has a variety of resources available to support your patients and their family members:
Guide to Quitting Smoking: Pintable guide with information and resources to support individuals who would like to quit smoking. www.cancer.org/Healthy/StayAwayfromTobacco/GuidetoQuittingSmoking/index
Desktop Helpers: Downloadable tools to help smokers plan for their “quit day”, deal with cravings, and provide support and resources to help them remain smoke free. www.cancer.org/Healthy/StayAwayfromTobacco/GreatAmericanSmokeout/desktop-helpers
Smokeout Tools and Resources: Printable resources including Great American Smokeout posters and table tents, “I am Quitting” Cards, the Great American Smokeout Employee Toolkit, and Great American Stickers.
New Web Site Launched for Nuclear Medicine and Molecular Imaging Patients
The Society of Nuclear Medicine (SNM) has launched a new patient-focused Web site, discoverMI.org, to provide patients with information about nuclear medicine and molecular imaging and how it can play a critical role in the detection, treatment and management of diseases.
The Web site focuses on three common disease areas—heart disease, cancer and brain disease. For each area, specific types of disease are detailed along with the various nuclear and molecular imaging procedures that are associated with each. General information on molecular imaging, an extensive glossary and a video library are also included on the site. Additionally, patients can stay up to date on the latest in molecular imaging news through Facebook and Twitter pages designed to complement the site.
DiscoverMI.org is supported by several patient advocacy groups that are a part of SNM’s Patient Advocacy Advisory Board (PAAB), including the Alzheimer’s Association, the American Thyroid Association, the Leukemia and Lymphoma Society, the Ovarian Cancer Alliance of Arizona, the Ovarian Cancer National Alliance, the American Heart Association, the Men’s Health Network and the Thyroid Cancer Survivors’ Association.
SEER Releases New United States Cancer Mortality Data, Cancer Statistics Review 2011
The SEER Cancer Statistics Review, 1975-2008 (CSR), published by NCI’s Surveillance Research Program, was updated on October 20, 2011 to include United States cancer mortality data in addition to previously posted materials released on April 15, 2011. The full report is available at: www.seer.cancer.gov/csr/Materials posted include:
The updated Cancer Statistics Review presents the most recent cancer incidence, survival, mortality, and prevalence statistics. Lifetime risk statistics will be added to the report as soon as they are available. All material in the SEER CSR report is in the public domain and may be reproduced or copied without permission. Citation of this source is, however, appreciated.
- SEER CSR, 1975-2008
- SEER Data, 1973-2008
- Updated Stat Fact Sheets and Fast Stats
- Delay Adjusted Incidence for SEER 9 and SEER 13
The latest SEER data were also released through SEER*Stat, statistical software that provides a mechanism for analyzing SEER and other cancer-related databases.
Attend the Event in Hospice and Palliative Care
The Annual Assembly of the American Academy of Hospice and Palliative Medicine and the Hospice and Palliative Nurses Association on March 7-10, 2012 in Denver, CO.
Open Your MindMake Connections
Be among those who gain knowledge directly from leaders in the field. Learn the latest scientific advances. Get inspired and invigorated by captivating speakers. Plenary sessions include discussions on bending the cost curve of medical care, ways men and women cope with illness and grief, social media, public policy and research, and refractory dyspnea in COPD.
Join the more than 2,000 hospice and palliative care professionals who meet once each year. In no other setting do so many of your peers come together to share best practices, ask questions, and build long-lasting relationships.
Bring It Home
Attending the Assembly will directly impact your work. You’ll approach your team with new knowledge of the latest scientific developments and a rekindled passion for the work you do.
Impact Patient Care
Think of what this will mean to your patients and their families. You will be able to offer them the ability to make the most informed decision regarding their care, and they will benefit most from your attendance.
Visit http://www.AnnualAssembly.org to learn more. Register by January 25, 2012, and save $100.
ICD-10-CM: Update for the Cancer Registrar Webinar
November 9, 2011, 2:00 p.m. ET
In this first of three webinars dedicated to ICD-10-CM, presenter Jennifer Ruhl, RHIT, CTR, will cover the update to ICD-10-CM and its impact on the job tasks of the cancer registrar. Ruhl will review the ICD-O-3 primary site codes and discuss how they relate to ICD-10-CM, along with ICD-9-CM and ICD-10; all of which appear on the casefinding list for cancer registrars. Register Today: http://www.ncra-usa.org/i4a/pages/index.cfm?pageid=3281#icd10
CSv02.03.02 Webinar: Colon
November 16, 2011, 2:00 p.m. ET
One live webinar in the CSv02.03.02 webinar series is scheduled before the December 31 deadline. Scheduled for Wednesday, November 16, at 2:00 p.m. ET, the 90-minute webinar will provide an overview of the topic area and an in-depth analysis of the specific site (colon). Earn 1.5 CE credits. Member price: $50; non-member price: $75. Learn More and Register: http://www.ncra-usa.org/i4a/pages/index.cfm?pageid=3691
Earn One CE for NCRA’s Webinar on Leadership
December 7, 2011, 2:00 p.m. ET
NCRA’s one hour webinar, A Leadership Primer for Cancer Registrars, is the first in a new series focused on professional development. Earn one CE credit.
Participants will learn how to:
- Recognize their inherent leadership skills
- Identify leadership attributes in others
- Learn how successful leaders build communication skills
- Create a personal plan-of-action to develop the skills needed to be an effective leader
Learn More: http://www.ncra-usa.org/i4a/pages/index.cfm?pageid=3281#leadership
Monthly Spotlight: American Medical Association
The Commission on Cancer regularly collaborates with over 50 member organizations in its mission to provide quality cancer care. This month we introduce the American Medical Association (AMA).
In July 2011, the AMA named James L. Madara, MD, as its new executive vice president and chief executive officer. "The American Medical Association is thrilled to have a proven medical leader like Dr. Madara serve as our next EVP/CEO," said Ardis D. Hoven, MD, chair, AMA Board of Trustees. "Dr. Madara is a strong strategic thinker and planner who has a track record of bringing people together to accomplish significant, ambitious, health-related goals and projects. Having overseen a $1.6 billion integrated academic medical center, Dr. Madara understands many of the complex clinical, academic, and business-related issues confronting medicine and health care today. His insight and perspective will be invaluable in helping the AMA tackle its agenda."Since 1847, the AMA has had one mission: to promote the art and science of medicine and the betterment of public health. Today, the core strategy used to carry out this mission is a concerted effort to help doctors help patients. AMA policy on issues in medicine and public health is decided through its democratic policy-making process, in the AMA House of Delegates.
AMA 2011 Strategic Issues:
- Cost of Health Care
- Quality of Care
- Access and Workforce
- Next Generation Physician Payment
- Prevention and Wellness
Recent Publications and/or Products:
JAMA – The Journal of the American Medical Association
JAMA has been published continuously since 1883, is an international peer-reviewed general medical journal published 48 times per year. JAMA is the most widely circulated medical journal in the world. http://www.jama.ama-assn.org/
American Medical News
American Medical News is the print and online news publication for physicians published by the American Medical Association. No other single publication covers the same spectrum of medical news. It has a large national circulation that cuts across geographic regions, practice settings, and medical specialties. http://www.amednews.com
For more information on this organization, please contact:
American Medical Association, 515 N. State St., Chicago, IL 60654
Monthly Spotlight: The Society of Thoracic Surgeons
The Commission on Cancer regularly collaborates with over 50 member
organizations in its mission to provide quality cancer care. This month
we introduce the Society of Thoracic Surgeons (STS).
Founded in 1964, the STS is a not-for-profit organization representing more than 6,300 surgeons, researchers, and allied health care professionals worldwide who are dedicated to ensuring the best possible outcomes for surgical procedures of the heart, lung, and esophagus, as well as other procedures within the chest.
The STS has established a new collaboration with the American Society of Clinical Oncology to develop an educational series focusing on the treatment of lung cancer. The program will provide an opportunity for the multidisciplinary team of medical and surgical oncologists, general surgeons, advanced cardiac care nurses, physician assistants, fellows, and other health care professionals to obtain a comprehensive review and update on cutting edge science, share clinical practice strategies, and most importantly, interact with and learn from a renowned faculty of experts from both societies who are experts in the field. The series of three e-learning courses, titled “Medical and Surgical Aspects of Lung Cancer Treatment” will be hosted on ASCO University®. The STS has also collaborated with the American College of Chest Physicians to develop a consensus statement with graded recommendations regarding the management of high-risk patients harboring stage I non small cell lung cancer.
News in Lung Cancer Screening:
The National Lung Cancer Screening Trial (NLST), published in June 2011, demonstrated that lung cancer mortality in a high-risk population can be reduced by low-dose CT screening. This is a landmark trial that will likely redefine lung cancer screening in appropriate patients. Unlike prior studies that failed to show a benefit from screening, the NLST was a large prospective randomized clinical trial with just over 53,000 participants (aged 55 - 74 years) with a cigarette smoking history of at least 30 pack-a-day years and, if former smokers, had quit within the last 15 years. Individuals in the NLST trial were randomized to screening by low-dose CT or by plain chest radiography. Three exams were given: the first at baseline, the second one year after baseline, and the third two years after baseline. The incidence of lung cancers was 645 cases per 100,000 person-years (1060 cancers) in the CT group and 572 cases per 100,000 person-years (941 cancers) in the radiography group (rate ratio, 1.13; 95 percent confidence interval, 1.03-1.23). The relative reduction in mortality (compared with radiography) from lung cancer with low-dose CT screening was 20 percent. The death rate from any cause in the CT screening group was reduced by 6.7 percent, compared to the radiography group. One death from lung cancer was prevented per 320 participants in screening. National medical societies such as the American Cancer Society and the National Comprehensive Care Network are developing guidelines for screening programs, but none are currently available.
 The National Lung Screening Trial Research Team (2011). Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med 2011;365:395-409.
For more information on this organization, please contact:
Nancy Gray Puckett, Director of Marketing and Communications, STS, 633 N. Saint Clair St., Suite 2320, Chicago, IL 60611
Website: www.sts.org | E-mail: firstname.lastname@example.org
Cancer Disparities: Causes and Evidence-Based Solutions Now Available
Springer Publishing Company is pleased to announce the October 2011 publication of:
Causes and Evidence-Based Solutions
American Cancer Society, / Elk, Ronit / Landrine, Hope
Cancer is not randomly distributed in the United States. Its incidence varies by race, ethnicity, socioeconomic status, and other geographic and demographic factors. This volume is the first to examine the biological, racial, and socioeconomic factors that influence cancer incidence and survival and presents 15 previously unpublished, evidence-based interventions that can be used to reduce and eliminate cancer disparities. To view a complete description and Table of Contents, please click on the book cover or title.
We would like to work with your association to promote this book to your members. We can offer your association discounting on quantities that are purchased for sale to your members.
Our discount schedule:
1 – 9 copies 20%
10 - 25 copies 25%
26 - 49 copies 30%
50 - 99 copies 35%
100 - 499 copies 40%
500- 999 copies 45%
1,000+ copies 50%
- These discounts are for non-returnable orders only.
- Shipping is additional.
- Shipment must be to one location only in the United States.
Or, you can announce the book on your website or newsletter and direct your members to our website for purchase – we would extend a discount to members who purchase through our website.
Please let us know if you would like to take advantage of either offer. We would be happy to send a gratis copy for your review. Thank you for your time and consideration.